Laurel Wealth Advisors, Inc. Biogen Inc. Transaction History

Laurel Wealth Advisors, Inc.

$1.01 Billion
Q4 2022

A detailed history of Laurel Wealth Advisors, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 1,038 shares of BIIB stock, worth $160,132. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,038

Previous 1,105 6.06%

Holding current value

$160,132

Previous $295,000 2.71%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $16,913 - $20,550	-67 Reduced 6.06%	1,038 $287,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $12,849 - $17,718	-66 Reduced 5.64%	1,105 $295,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $147,031 - $174,847	-784 Reduced 40.1%	1,171 $239,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $37,010 - $46,630	-191 Reduced 8.9%	1,955 $412,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $283,482 - $364,316	1,266 Added 143.86%	2,146 $515,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $7,357 - $9,595	-26 Reduced 2.87%	880 $249,000
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $49,987 - $80,039	193 Added 27.07%	906 $314,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $173,223 - $202,941	713 New	713 $200,000
Q4 2020 Mar 03, 2021	SELL	$236.26 - $355.63 $176,249 - $265,299	-746 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $24,094 - $27,819	-91 Reduced 10.87%	746 $212,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $25,348 - $33,569	98 Added 13.26%	837 $224,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $25,809 - $32,739	-96 Reduced 11.5%	739 $234,000
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $10,782 - $14,899	-49 Reduced 5.54%	835 $248,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $3,044 - $3,414	14 Added 1.61%	884 $206,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $4,385 - $4,834	-20 Reduced 2.25%	870 $203,000
Q1 2019 May 16, 2019	SELL	$216.71 - $338.96 $100,336 - $156,938	-463 Reduced 34.22%	890 $210,000
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $49,573 - $62,789	178 Added 15.15%	1,353 $407,000
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $2,641 - $3,454	9 Added 0.77%	1,175 $415,000
Q2 2018 Aug 20, 2018	BUY	$257.52 - $306.91 $6,695 - $7,979	26 Added 2.28%	1,166 $338,000
Q1 2018 May 16, 2018	SELL	$260.13 - $367.91 $6,763 - $9,565	-26 Reduced 2.23%	1,140 $312,000
Q4 2017 Feb 15, 2018	SELL	$307.64 - $344.58 $4,614 - $5,168	-15 Reduced 1.27%	1,166 $371,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $50,325 - $59,014	179 Added 17.86%	1,181 $369,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,002	1,002 $271,000

Others Institutions Holding BIIB

# of Institutions

1,039

Shares Held

132M

Call Options Held

2.84M

Put Options Held

2.54M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.

Account

Laurel Wealth Advisors, Inc. Biogen Inc. Transaction History